PA
DTIL icon

Perceptive Advisors’s Precision BioSciences DTIL Stock Holding History

Perceptive Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-426,293
Closed -$3.82M – 104
2024
Q3 		$3.82M Hold
426,293
– – 0.08% 85
2024
Q2 		$4.15M Sell
426,293
-54,190
-11% -$638K 0.1% 82
2024
Q1 		$6.52M Buy
+480,483
New +$5.88M 0.11% 81

Other funds holding DTIL

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Perceptive Advisors's DTIL Position: Q4 2024 in Review

Perceptive Advisors sold out of Precision BioSciences (DTIL) in Q4 2024, closing a stake of 426,293 shares — an estimated $3.82M sold.

Perceptive Advisors first reported a position in DTIL in Q1 2024 and held it in 3 quarters. The position peaked at $6.52M in Q1 2024. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

  • Perceptive Advisors reported no remaining Precision BioSciences position as of Q4 2024 after selling out during the quarter.
  • Perceptive Advisors sold 426,293 Precision BioSciences shares in Q4 2024, an estimated $3.82M.
  • Perceptive Advisors first reported a position in Precision BioSciences in Q1 2024 and held it in 3 quarters.
  • Perceptive Advisors's Precision BioSciences position peaked at $6.52M in Q1 2024.
  • 55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on Perceptive Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.